Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §102 only | 2 (40%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUTT, ADITI | 2 | 47.4% | +47.1% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.3% | +42.1% |
| SWIFT, CANDICE LEE | 1 | 58.3% | +38.5% |
| MONDESI, ROBERT B | 1 | 35.8% | +1.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17234690 | BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT | DUTT, ADITI | 42d overdue |
| 18359633 | Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s) | DUTT, ADITI | 28d overdue |
| 18414311 | Albumin-Free Botulinum Toxin Formulations | OGUNBIYI, OLUWATOSIN A | 26d |
| 18278169 | METHODS OF AND COMPOSITIONS FOR TREATMENT OF UPPER LIMB SPASTICITY | SWIFT, CANDICE LEE | 47d |
| Art Unit | Apps |
|---|---|
| 1675 | 2 |
| 1645 | 1 |
| 1657 | 1 |
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18414311 | Albumin-Free Botulinum Toxin Formulations | OGUNBIYI, OLUWATOSIN A | 1645 | §102 | Non-Final OA | 26d | Pending | Jan 16, 2024 |
| 18278169 | METHODS OF AND COMPOSITIONS FOR TREATMENT OF UPPER LIMB SPASTICITY | SWIFT, CANDICE LEE | 1657 | Other | Final Rejection | 47d | Pending | Aug 21, 2023 |
| 18359633 | Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s) | DUTT, ADITI | 1675 | §103 | Final Rejection | 28d overdue | Pending | Jul 26, 2023 |
| 18031861 | METHODS FOR TREATING CERVICAL DYSTONIA | MONDESI, ROBERT B | 1652 | §103 | Final Rejection | 114d overdue | Pending | Apr 13, 2023 |
| 17234690 | BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT | DUTT, ADITI | 1675 | §102 | Final Rejection | 42d overdue | Pending | Apr 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial